LITTLE KNOWN FACTS ABOUT PPAP HCL.

To furnish direct proof that the peculiar enhancement of catecholaminergic action while in the brain in animals handled with a little dose of (−)deprenyl is unrelated to MAO inhibition, we developed within the early '90s a family of deprenyl analogues devoid of the MAO-B inhibitory influence (Knoll et alAs a result of PPAP, suppliers and clients